Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria

NCT01642017 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment rate

Conditions

Metastatic Cancer (Different Solid Tumour Types)

Interventions

DRUG: Pazopanib

Sponsor

Institut Claudius Regaud

Collaborators

[object Object]